Skip to content

Causes of Visual Loss in Retinal Disease

Observational Study of Visual Outcomes in Retinal Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01613963
Enrollment
2000
Registered
2012-06-07
Start date
2012-05-31
Completion date
2012-12-31
Last updated
2012-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleritis, Uveitis

Keywords

Uveitis, Scleritis

Brief summary

This is a study of visual outcomes in retinal disease that seeks to identify the causes of visual loss. This data will be used to predict which patients are at risk of losing vision and how they can be better treated.

Detailed description

This is a study of visual outcomes in retinal disease. It is an observational study of patients who have been seen in the retinal clinic, and involves a retrospective casenotes analysis to identify patients who have suffered visual loss and the reason for that visual loss. These data will be analysed to enable the identification of factors that predict visual loss in patients who present earlier in the course of their disease.

Interventions

DRUGImmunosuppressive Agents

Treatment with systemic corticosteroids and/or immunosuppressive agents Treatment with local corticosteroids and other drugs

Sponsors

Royal Surrey County Hospital NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with a diagnosis of ocular inflammation * patients with at least 6 months of follow-up

Exclusion criteria

* patients without a diagnosis of ocular inflammation * patients with less than 6 months of follow-up

Design outcomes

Primary

MeasureTime frameDescription
Visual acuity at 5 years5 yearsBest-corrected visual acuity at 5 years

Secondary

MeasureTime frameDescription
Visual acuity at 10 years10 yearsBest corrected visual acuity at 10 years
Source of referralBaselineCategorised as A&E/GP referral/Optician referral/Tertiary referral
LateralityBaselineCategorised as: Right eye/Left eye/Bilateral
Anatomical diagnosisBaselineCateogorised as: Acute anterior uveitis / Chronic anterior uveitis / Fuchs heterochromic cyclitis / Intermediate uveitis / Pars planitis / Posterior Uveitis / Panuveitis / Episcleritis / Scleritis
Aetiological diagnosisBaselineDiagnosed as: Viral / Bacterial / Fungal / Parasitic / Inflammatory / Malignant
Associated systemic diseaseBaselineAny associated systemic disease, e.g. HLA-B27 associated disease, Behcet's disease, multiple sclerosis, Vogt-Koyanagi-Harada syndrome, rheumatoid arthritis, collagen vascular disease, tuberculosis, granulomatosis with polyangiitis
Complications of disease and causes of visual loss at 5 years5 yearsCategorised into: Corneal clarity problems / cataract / vitreous debris / retinal detachment / cystoid macular edema / retinal pigment epithelium atrophy / macular scarring / epiretinal membrane / macular hole / steroid response / glaucoma / other optic neuropathy / hypotony & phthisis / other
Complications of disease and causes of visual loss at 10 years10 yearsCategorised into: Corneal clarity problems / cataract / vitreous debris / retinal detachment / cystoid macular edema / retinal pigment epithelium atrophy / macular scarring / epiretinal membrane / macular hole / steroid response / glaucoma / other optic neuropathy / hypotony & phthisis / other
Complications of disease and causes of visual lossUp to 10 yearsCategorised into: Corneal clarity problems / cataract / vitreous debris / retinal detachment / cystoid macular edema / retinal pigment epithelium atrophy / macular scarring / epiretinal membrane / macular hole / steroid response / glaucoma / other optic neuropathy / hypotony & phthisis / other
Treatment measures employedUp to 10 yearsCategorised into: Topical treatment / periocular steroid / intraocular steroid / intraocular other agent / Glaucoma treatment / systemic immunosuppressive agents
Complications of disease and treatmentUp to 10 yearsCategorised into: 1. Local complications: Raised intraocular pressure / cataract / endophthalmitis / other 2. Systemic complications: Diabetes / hypertension / cholesterol / liver function / bone density loss / other
Surgical proceduresUp to 10 yearsList and dates of any intraocular surgery performed during the study
Burden of disease - appointmentsUp to 10 yearsNumber of outpatient appointments over the course of the study
Burden of disease - outpatient proceduresUp to 10 yearsNumber of outpatient procedures over the course of the study
Burden of disease - inpatient proceduresUp to 10 yearsNumber of inpatient procedures over the course of the study
Blind registrationUp to 10 yearsYear of any registration as partially sighted or blind

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026